Elutia Inc (NAS:ELUT)

Q1 2025 Elutia Inc Earnings Call Transcript

May 8, 2025 / 09:00 PM GMT

Release Date Price: $1.99 (+3.65%)

Transcript 10-Q8-K

Key Points

Positve

Elutia Inc (ELUT) reported a 31% year-over-year growth in its bio envelope division, reaching $3.1 million in revenue.
The company successfully launched its LEU Pro product, which now constitutes 52% of the bio envelope revenue, showing an 84% increase from the previous quarter.
Elutia Inc (ELUT) formed a strategic partnership with Boston Scientific, expanding its commercial footprint to over 900 sales professionals.
The company opened a new facility in Gaithersburg, Maryland, to enhance manufacturing capacity and reduce production costs.
Elutia Inc (ELUT) received an Edison Award for innovation in post-surgical recovery, highlighting its commitment to advancing medical technology.

Negative

Revenue from the Simple Derm division decreased from $3.6 million last year to $2.6 million this quarter.
The cardiovascular products division reported only $300,000 in sales, as it was still transitioning from an outside distributor.
Overall sales were down from the previous year, despite a sequential increase from the fourth quarter.
The company faced production constraints due to the antibiotic component of LEU Pro, necessitating the opening of a new facility.
Elutia Inc (ELUT) had to manage cash flow carefully, including a registered direct offering and amendments to financial agreements to conserve cash.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ELUT.OQ - Elutia Inc
Q1 2025 Elutia Inc Earnings Call
May 08, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Yes, AND AND more.

No on that.

Good afternoon, ladies and gentlemen.

Welcome to it to the elution First Quarter 2025 financial results conference call.

You would like to ask a question, please press star one on your telephone key pad to join the queue.

Please be advised that today's conference call is being recorded.

I would now like to hand the conference over to Matt Steinberg with FIG Partners.

Please go ahead.

Thank you, operator, and thank you all for participating in today's call.

Earlier today, Avinger released financial results for the quarter ended March 31st, 2025.

Copy of the press release is available on the company's website.

Before

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.